Report Detail

Pharma & Healthcare Global Iohexol Injection Market Research Report 2021

  • RnM4313733
  • |
  • 27 April, 2021
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Iohexol Injection Market Overview

  • 1.1 Product Overview and Scope of Iohexol Injection
  • 1.2 Iohexol Injection Segment by Type
    • 1.2.1 Global Iohexol Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 350mg I/ml
    • 1.2.3 240mg I/ml
    • 1.2.4 300mg I/ml
    • 1.2.5 Others
  • 1.3 Iohexol Injection Segment by Application
    • 1.3.1 Global Iohexol Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Global Iohexol Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Iohexol Injection Revenue 2016-2027
    • 1.4.2 Global Iohexol Injection Sales 2016-2027
    • 1.4.3 Iohexol Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Iohexol Injection Market Competition by Manufacturers

  • 2.1 Global Iohexol Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Iohexol Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Iohexol Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Iohexol Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Iohexol Injection Market Competitive Situation and Trends
    • 2.5.1 Iohexol Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Iohexol Injection Players Market Share by Revenue
    • 2.5.3 Global Iohexol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Iohexol Injection Retrospective Market Scenario by Region

  • 3.1 Global Iohexol Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Iohexol Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Iohexol Injection Market Facts & Figures by Country
    • 3.3.1 North America Iohexol Injection Sales by Country
    • 3.3.2 North America Iohexol Injection Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Iohexol Injection Market Facts & Figures by Country
    • 3.4.1 Europe Iohexol Injection Sales by Country
    • 3.4.2 Europe Iohexol Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Iohexol Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Iohexol Injection Sales by Region
    • 3.5.2 Asia Pacific Iohexol Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Iohexol Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Iohexol Injection Sales by Country
    • 3.6.2 Latin America Iohexol Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Iohexol Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Iohexol Injection Sales by Country
    • 3.7.2 Middle East and Africa Iohexol Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Iohexol Injection Historic Market Analysis by Type

  • 4.1 Global Iohexol Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Iohexol Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Iohexol Injection Price by Type (2016-2021)

5 Global Iohexol Injection Historic Market Analysis by Application

  • 5.1 Global Iohexol Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Iohexol Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Iohexol Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GE Healthcare
    • 6.1.1 GE Healthcare Corporation Information
    • 6.1.2 GE Healthcare Description and Business Overview
    • 6.1.3 GE Healthcare Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GE Healthcare Iohexol Injection Product Portfolio
    • 6.1.5 GE Healthcare Recent Developments/Updates
  • 6.2 Imax
    • 6.2.1 Imax Corporation Information
    • 6.2.2 Imax Description and Business Overview
    • 6.2.3 Imax Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Imax Iohexol Injection Product Portfolio
    • 6.2.5 Imax Recent Developments/Updates
  • 6.3 Grupo Juste
    • 6.3.1 Grupo Juste Corporation Information
    • 6.3.2 Grupo Juste Description and Business Overview
    • 6.3.3 Grupo Juste Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Grupo Juste Iohexol Injection Product Portfolio
    • 6.3.5 Grupo Juste Recent Developments/Updates
  • 6.4 Daiichi Sankyo
    • 6.4.1 Daiichi Sankyo Corporation Information
    • 6.4.2 Daiichi Sankyo Description and Business Overview
    • 6.4.3 Daiichi Sankyo Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Daiichi Sankyo Iohexol Injection Product Portfolio
    • 6.4.5 Daiichi Sankyo Recent Developments/Updates
  • 6.5 Takeda
    • 6.5.1 Takeda Corporation Information
    • 6.5.2 Takeda Description and Business Overview
    • 6.5.3 Takeda Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Takeda Iohexol Injection Product Portfolio
    • 6.5.5 Takeda Recent Developments/Updates
  • 6.6 Fuji Pharma
    • 6.6.1 Fuji Pharma Corporation Information
    • 6.6.2 Fuji Pharma Description and Business Overview
    • 6.6.3 Fuji Pharma Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Fuji Pharma Iohexol Injection Product Portfolio
    • 6.6.5 Fuji Pharma Recent Developments/Updates
  • 6.7 Towaseiyaku
    • 6.6.1 Towaseiyaku Corporation Information
    • 6.6.2 Towaseiyaku Description and Business Overview
    • 6.6.3 Towaseiyaku Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Towaseiyaku Iohexol Injection Product Portfolio
    • 6.7.5 Towaseiyaku Recent Developments/Updates
  • 6.8 Hikari Pharmaceutical
    • 6.8.1 Hikari Pharmaceutical Corporation Information
    • 6.8.2 Hikari Pharmaceutical Description and Business Overview
    • 6.8.3 Hikari Pharmaceutical Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Hikari Pharmaceutical Iohexol Injection Product Portfolio
    • 6.8.5 Hikari Pharmaceutical Recent Developments/Updates
  • 6.9 YRPG
    • 6.9.1 YRPG Corporation Information
    • 6.9.2 YRPG Description and Business Overview
    • 6.9.3 YRPG Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 YRPG Iohexol Injection Product Portfolio
    • 6.9.5 YRPG Recent Developments/Updates
  • 6.10 BeiLu Pharma
    • 6.10.1 BeiLu Pharma Corporation Information
    • 6.10.2 BeiLu Pharma Description and Business Overview
    • 6.10.3 BeiLu Pharma Iohexol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 BeiLu Pharma Iohexol Injection Product Portfolio
    • 6.10.5 BeiLu Pharma Recent Developments/Updates

7 Iohexol Injection Manufacturing Cost Analysis

  • 7.1 Iohexol Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Iohexol Injection
  • 7.4 Iohexol Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Iohexol Injection Distributors List
  • 8.3 Iohexol Injection Customers

9 Iohexol Injection Market Dynamics

  • 9.1 Iohexol Injection Industry Trends
  • 9.2 Iohexol Injection Growth Drivers
  • 9.3 Iohexol Injection Market Challenges
  • 9.4 Iohexol Injection Market Restraints

10 Global Market Forecast

  • 10.1 Iohexol Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Iohexol Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Iohexol Injection by Type (2022-2027)
  • 10.2 Iohexol Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Iohexol Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Iohexol Injection by Application (2022-2027)
  • 10.3 Iohexol Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Iohexol Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Iohexol Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    350mg I/ml
    240mg I/ml
    300mg I/ml
    Others

    Segment by Application
    Hospitals
    Clinics

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GE Healthcare
    Imax
    Grupo Juste
    Daiichi Sankyo
    Takeda
    Fuji Pharma
    Towaseiyaku
    Hikari Pharmaceutical
    YRPG
    BeiLu Pharma


    Summary:
    Get latest Market Research Reports on Iohexol Injection. Industry analysis & Market Report on Iohexol Injection is a syndicated market report, published as Global Iohexol Injection Market Research Report 2021. It is complete Research Study and Industry Analysis of Iohexol Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,050.30
    3,075.45
    4,100.60
    2,380.90
    3,571.35
    4,761.80
    315,201.00
    472,801.50
    630,402.00
    212,860.00
    319,290.00
    425,720.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report